TAIM
CELG

TD Ameritrade Investment Management’s Celgene Corp CELG Stock Holding History

TD Ameritrade Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11
Closed -$1K – 697
2019
Q1 		$1K Sell
11
-575
-98% -$50.3K ﹤0.01% 568
2018
Q4 		$38K Buy
586
+339
+137% +$25K ﹤0.01% 255
2018
Q3 		$22K Buy
247
+224
+974% +$19.8K ﹤0.01% 277
2018
Q2 		$2K Buy
+23
New +$1.91K ﹤0.01% 399

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

TD Ameritrade Investment Management's CELG Position: Q2 2019 in Review

TD Ameritrade Investment Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 11 shares — an estimated $1K sold.

TD Ameritrade Investment Management first reported a position in CELG in Q2 2018 and held it in 4 quarters. The position peaked at $38K in Q4 2018. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • TD Ameritrade Investment Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 11 Celgene Corp shares in Q2 2019, an estimated $1K.
  • TD Ameritrade Investment Management first reported a position in Celgene Corp in Q2 2018 and held it in 4 quarters.
  • TD Ameritrade Investment Management's Celgene Corp position peaked at $38K in Q4 2018.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on TD Ameritrade Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.